Lates News

Cabaletta Bio (CABA.US): The Q3 2025 financial report achieved revenue of $0, compared to the previous value of $0 and an expected value of $833,330. Earnings per share were -$0.44, compared to the previous value of -$0.62 and an expected value of -$0.47.